Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

  Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

Business Wire

NEW YORK -- November 07, 2012

Bristol-Myers Squibb Company (NYSE: BMY) will present at the 2012 Credit
Suisse Healthcare Conference on Wednesday, November 14, 2012, in Phoenix.
Douglas Manion, senior vice president, Development, Neuroscience, Virology and
Japan, will make a formal presentation about the company at 1:30 p.m. MT (3:30
p.m. ET).

Investors and the general public are invited to listen to a live webcast of
the presentation at http://investor.bms.com. Materials related to the
presentation will be available at the same website at the start of the live
webcast. An archived edition of the presentation will be available later that
day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.

Contact:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com